Visual BRAND identity + SQUARESPACE website

Kynos Therapeutics

Clinical-stage biotech company Kynos Therapeutics is developing an innovative portfolio of first-in-class medicines that fulfil a gap in available treatment for acute and chronic inflammation. 

Launched in April 2022 by Professors Damien Mole and Scott Webster, the Kynos team began their journey in partnership with the University of Edinburgh and GlaxoSmithKline (GSK), before establishing itself as an independent enterprise. 

Services

  • Brand Strategy

  • Creative direction

  • Visual brand identity design

  • Collateral design

  • Squarespace 7.1 website design + development

  • SEO optimisation

  • Marketing support

Time

  • 3 months: January - March 2024

  • ...She managed the process thoughtfully to ensure the brief was fully met...

    “Krisha took the time to understand the company and our objectives for a new website. She managed the process thoughtfully to ensure the brief was fully met. The end result was a polished website designed for the target audience of business partners and investors which clearly communicated Kynos’ innovative science and its progress in the development of a novel therapeutic.”

    - Jonathan Savidge, CEO of Kynos Therapeutics Ltd (before it was acquired by Dr. Falk Pharma)

Item 1 of 1

LEt’s discuss your project…

Previous
Previous

The Good Plant Company - Squarespace website redesign and development

Next
Next

Crocstar - Squarespace 7.1 membership website redesign and development